Jennifer T. Feldman is a dynamic healthcare business development leader with over 23 years of experience driving innovation, strategic partnerships, and commercial success in the oncology, pharmaceuticals, and biotechnology sectors. With an extensive background in medical devices, tissue diagnostics, and therapeutics, she has established herself as a key player in advancing cutting-edge healthcare solutions. Her expertise spans clinical pathology, research-use-only applications, translational medicine, and companion diagnostics, making her an invaluable asset in the ever-evolving healthcare landscape.
Currently, Jennifer serves as a Technical Applications Specialist – US-Based National Accounts at Biocare Medical, where she bridges the gap between novel tissue diagnostic technologies and their implementation across hospitals, integrated delivery networks (IDNs), reference laboratories, and physician offices. She is instrumental in educating key stakeholders, optimizing advanced staining platforms, and driving the adoption of innovative solutions that enhance patient outcomes. Her ability to seamlessly integrate technical expertise with strategic sales and marketing acumen positions her as a leader in transforming healthcare organizations.
Prior to her role at Biocare Medical, Jennifer was the Senior Open Innovation Partnerships Manager – National and Global Accounts at Leica Biosystems, a Danaher company. In this role, she spearheaded high-profile collaborations with key industry partners, guiding the integration of emerging technologies into commercial portfolios. She successfully managed partnerships with ACD, Akoya, Molecular Instruments, NanoString, and Ultivue, from initial agreements to co-marketing and commercial launches. Her work in business case development, product integration, and field training significantly contributed to Leica Biosystems’ position as an industry leader in tissue diagnostics.
Jennifer’s career also includes impactful roles at Werfen, Inova Diagnostics, BioReference Laboratories, Accelerate Diagnostics, and Roche Tissue Diagnostics. She has consistently excelled in driving sales, technical applications, marketing strategies, and process improvement initiatives across healthcare organizations, academic medical centers, and clinical research entities. Her ability to cultivate relationships with key opinion leaders (KOLs), manage complex negotiations, and ensure compliance with FDA, CAP, and CLIA regulations has set her apart as a results-driven leader.
With an MBA in International Business from Louisiana State University and certifications in Histotechnology (HTL) and Immunohistochemistry (QIHC) from the American Society of Clinical Pathology, Jennifer combines business acumen with deep technical expertise. She has further enhanced her skill set through Amazon Web Services (AWS) training in cloud computing, machine learning, and artificial intelligence, positioning her at the forefront of digital transformation in healthcare.
Jennifer is a sought-after speaker and has presented at numerous industry trade shows, medical conferences, and state-level events, sharing insights on oncology diagnostics, technical applications, and transformative marketing strategies. Her international exposure, particularly in the United Kingdom, her relationships in Australia, Germany, China, India, and visits to Africa have allowed her to further enhance her global perspective.
As an advocate for the American Society of Clinical Pathology, College of American Pathologist, National Society of Histotechnology, and the American Association for Cancer Research, Jennifer remains deeply engaged in industry advancements. While she is not currently serving on any boards, she is eager to leverage her wealth of experience to provide strategic oversight, foster innovation, and drive growth in organizations focused on healthcare advancements.
Outside of her professional endeavors, Jennifer enjoys running, practicing yoga, and spending quality time with her family. A lifelong learner and visionary leader, she is committed to making a lasting impact in the healthcare field by bringing fresh perspectives, identifying emerging opportunities, and fostering transformative change.
Character: Jennifer Feldman is a dedicated and results-driven leader who thrives on innovation, continuous learning, and making a meaningful impact in healthcare.
Knowledge: With over 23 years of experience, she possesses deep expertise in oncology diagnostics, medical devices, business development, and regulatory compliance.
Strategic: Jennifer excels in identifying growth opportunities, forging high-value partnerships, and integrating emerging technologies to drive competitive advantage.
Communication: A skilled communicator, she effectively engages with key opinion leaders, industry stakeholders, and cross-functional teams to drive adoption and execution of transformative healthcare solutions.
